IP Library Granted Patent US 12,203,939
Granted Patent B2
US 12,203,939 · App. 17/074,224 · Granted Jan 21, 2025

Quantitative massively parallel proteomics

Inventors: Ian Peikon (Bethpage, NY); Gary Tong (Berkeley, CA); Daniel Liu (Berkeley, CA); Ci Chu (Palo Alto, CA)
Assignee: Verily Life Sciences LLC
G01N33/6845C12Q1/6804G01N33/58G01N2458/10G01N2570/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,203,939
App. No.
17/074,224
Granted
Jan 21, 2025
Kind
B2
Abstract

Provided herein are compositions and methods for the identification of an expression profile in a single cell or population of cells. Kits for use with the disclosed methods are also provided, including antibodies, with a unique molecular identifier and antibody identifier, and primers for amplification of the antibody identifier sequence.

Claims (15)

1. A method of identifying an expression profile in a single cell of a population of cells, comprising:

a) contacting a population of cells with a plurality of antibodies under conditions that promote specific binding of the antibodies to target antigens of the cells, wherein each antibody in the plurality is capable of binding to a unique target antigen in one or more cells, wherein each antibody is conjugated to an oligonucleotide via thiol/maleimide conjugation, and wherein the oligonucleotide comprises a unique molecular identifier sequence and an antibody identifier sequence corresponding to the unique target antigen;

b) separating single cells of the population into individual compartments, wherein each compartment further comprises an oligonucleotide comprising a unique cellular identifier sequence that corresponds to the single cell in each compartment;

c) lysing the single cells with an agent that extracts proteins and nucleic acids from the cells, wherein the nucleic acids comprise RNA and/or DNA;

d) amplifying the unique molecular identifier sequences and antibody identifier sequences in each individual compartment, using the oligonucleotide comprising the unique cellular identifier sequence;

e) analyzing the amplified unique molecular identifier sequences and antibody identifier sequences to identify the expression profile of each single cell, wherein the unique molecular identifier sequences reduce bias in the analysis; and

f) analyzing the RNA extracted from the cells to identify a transcriptomic profile of each single cell and/or the DNA extracted from the cells to obtain genomic information of each single cell.

2. The method of claim 1 , wherein the population of cells is fixed and permeabilized prior to contacting the population with the plurality of antibodies.

3. The method of claim 1 , wherein the cellular identifier sequence corresponds to a well in a tissue culture plate.

4. The method of claim 1 , wherein analyzing comprises sequencing the amplified unique molecular identifier sequences and antibody identifier sequences.

5. The method of claim 4 , wherein the amplification products from the individual compartments are pooled prior to sequencing.

6. The method of claim 5 , wherein the pooled sequencing results are deconvoluted using the unique cellular identifier sequences to identify the expression profile of a single cell associated with each unique cellular identifier sequence.

7. The method of claim 1 , wherein the individual compartments are wells of a tissue culture plate or microfluidic droplets.

8. The method of claim 1 , wherein each individual compartment further comprises a single bead that includes the oligonucleotide including the unique cellular identifier sequence that corresponds to the single cell in each compartment.

9. The method of claim 1 , wherein the unique cellular identifier oligonucleotide is between about five and about fifty nucleotides in length.

Assignments (2)
CHANGE OF ADDRESS Recorded Nov 19, 2024
From: VERILY LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 069390/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2022
From: PEIKON, IAN; TONG, GARY; LIU, DANIEL; CHU, CI
To: VERILY LIFE SCIENCES LLC
Reel/Frame 059326/0248 →
Continuity (3)
Continuation 15656423 · Jul 21, 2017
Provisional Application 62365542 · Jul 22, 2016
Related Publication 20210132078A1 · May 6, 2021
References Cited (33)
US 10809266B2 · Peikon et al. · 2020 [cited by applicant]
US 20070003950A1 · Shen et al. · 2007 [cited by applicant]
US 20100209454A1 · Wimmer · 2010 [cited by examiner]
US 20140256588A1 · Glezer et al. · 2014 [cited by applicant]
US 20150100244A1 · Hannum · 2015 [cited by examiner]
US 20150376609A1 · Hindson et al. · 2015 [cited by applicant]
US 20160115474A1 · Jelinek · 2016 [cited by examiner]
US 20180024139A1 · Peikon et al. · 2018 [cited by applicant]
US 20180044731A1 · Valouev · 2018 [cited by examiner]
US 20180320241A1 · Nolan · 2018 [cited by applicant]
US 20190025299A1 · Vigneault · 2019 [cited by examiner]
WO 2016100976 · 2016 [cited by applicant]
WO WO2016100976A2 · 2016 [cited by examiner]
WO WO2017075294A1 · 2017 [cited by examiner]
WO 2018017949 · 2018 [cited by applicant]
Application No. EP17748996.0 , Office Action, Mailed on Aug. 17, 2022, 5 pages. [cited by applicant]
BD Biosciences, Intracellular FLow Cytometry, 2012,. [cited by applicant]
Fluidigm, Helios, a CyTOF System, 2015, https://www.fluidigm.com/products/helios#overview. [cited by applicant]
U.S. Appl. No. 15/656,423 , Final Office Action, Mailed on Jan. 27, 2020, 9 pages. [cited by applicant]
U.S. Appl. No. 15/656,423 , Non-Final Office Action, Mailed on Jul. 31, 2019, 10 pages. [cited by applicant]
U.S. Appl. No. 15/656,423 , Notice of Allowance, Mailed on Jun. 8, 2020, 8 pages. [cited by applicant]
Ahram et al., “Estimation of membrane proteins in the human proteome”, In silico biology 6.5 (2006): 379-386. [cited by applicant]
Alves et al., “Conjugation of a Reactive Thiol at the Nucleotide Binding Site for Site-Specific Antibody Functionalization”, Bioconjugate Chemistry, vol. 25, No. 7, 2014, pp. 1198-1202. [cited by applicant]
Duban-Deweer et al., “Proteomic Analysis of Plasma Membrane Proteins in an In Vitro Blood-Brain Barrier Model”, Proteomics—Human Diseases and Protein Functions, Feb. 10, 2012, pp. 397-398. [cited by applicant]
Application No. EP17748996.0 , Office Action, Mailed on Sep. 10, 2020, 6 pages. [cited by applicant]
Gaur , “Prokaryotic and eukaryotic non-membrane proteins have biased amino acid distribution”, J Comput Sci & Syst Biol 2.6 (2009): 298-299. [cited by applicant]
Green , “Avidin”, Advances in protein chemistry 29 (1975): 85-133 (abstract only). [cited by applicant]
Maier et al., “Correlation of mRNA and protein in complex biological samples”, FEBS letters 583.24 (2009): 3966-3973. [cited by applicant]
Ong et al., “Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics”, Molecular & cellular proteomics 1.5 (2002): 376-386. [cited by applicant]
Application No. PCT/US2017/043273 , International Preliminary Report on Patentability, Mailed on Jan. 31, 2019, 8 pages. [cited by applicant]
PCT/US2017/043273 , “PCT Search Report”, Nov. 3, 2017, 14 pages. [cited by applicant]
Wertz et al., “Influence of water on protein structure. An analysis of the preferences of amino acid residues for the inside or outside and for specific conformations in a protein molecule”, Macromolecules 11.1 (1978): … [cited by applicant]
Application No. EP17748996.0 , Office Action, Mailed on Apr. 24, 2024, 4 pages. [cited by applicant]